What's happening
This resolution urges Governor Kathy Hochul to proclaim February 28, 2023, as Rare Disease Day in New York to raise awareness.
Why it matters
Highlights the urgent need for improved diagnosis and treatment. The resolution points out that over 95% of rare diseases lack FDA-approved treatments and that patients typically face six to eight years before receiving a correct diagnosis, underlining significant gaps in the current healthcare system.
Emphasizes the economic and social burden on patients and families. It notes that treatments for rare diseases, when available, are often more expensive than for common diseases, and that patients struggle to find knowledgeable physicians and adequate social support.
Draws attention to the broad impact and research significance. With 1 in 10 New Yorkers affected by rare diseases and half of those impacted being children, the resolution stresses that rare disease research can also advance understanding and therapies for more common conditions.
Underscores momentum and hope in medical research. The text highlights recent legislative actions, the establishment of advisory groups, and the development of over 560 medicines targeting rare diseases—showing increased advocacy, scientific progress, and hope for improved outcomes.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Headline styles
Declare Rare Disease Day
Plain English, a few words. Used as the page title.
Sponsors
Assembly Member · Assembly District 108
1 Multi-sponsor
History
- Adopted
- Referred to calendar
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
Assembly Resolution No. 124 BY: M. of A. McDonald MEMORIALIZING Governor Kathy Hochul to proclaim
February 28, 2023, as Rare Disease Day in the State of New York WHEREAS, It is the custom of this Legislative Body to recognize official days set aside to increase awareness of serious issues that affect the lives of citizens of New York State; and WHEREAS,… Show allHide
February 28, 2023, as Rare Disease Day in the State of New York WHEREAS, It is the custom of this Legislative Body to recognize official days set aside to increase awareness of serious issues that affect the lives of citizens of New York State; and WHEREAS, Attendant to such concern, and in full accord with its long-standing traditions, it is the sense of this Legislative Body to memorialize Governor Kathy Hochul to proclaim February 28, 2023, as Rare Disease Awareness Day in the State of New York, in conjunction with the observance of National Rare Disease Day; and WHEREAS, National Rare Disease Day is an observance to raise awareness of rare diseases and diseases of unmet need, few of which have cures or specific drugs to treat symptoms, and are often not diagnosed for many years; and WHEREAS, 2023 marks the 15th Anniversary of Rare Disease Day in the United States; the first Rare Disease Day was held in 2008 on February 29th, a 'rare' date which happens only once every four years; ever since then, Rare Disease Day has taken place on the last day of February, a month known for having a 'rare' number of days; and WHEREAS, Rare Disease Day was established for the reason, according to the European Organization for Rare Diseases (EURORDIS), that treatment for many rare diseases and diseases of unmet need is insufficient, as are the social networks to support individuals with rare diseases and diseases of unmet need and their families; and WHEREAS, One year later, in 2009, Rare Disease Day went global as the National Organization of Rare Disorders (NORD) mobilized 200 rare disease patient advocacy organizations in the United States in an effort to coordinate activities and better promote the day; and WHEREAS, In 2013, in recognition of the needs of patients with rare diseases, Albany Medical Center and College established the Albany Medical Center's Rare Disease Forum, which was the genesis of the New York State Rare Disease Alliance, whose purpose is to promote faster diagnosis of rare diseases, research into therapies and cures, and to foster wider public recognition of public health problems affecting
25-30 million Americans; 1 in 10 New Yorkers suffer from a rare disease; and WHEREAS, There are nearly 7,000 diseases and conditions considered rare; it is paramount to stress the importance of early detection of said diseases, as well as work to minimize the… Show allHide
25-30 million Americans; 1 in 10 New Yorkers suffer from a rare disease; and WHEREAS, There are nearly 7,000 diseases and conditions considered rare; it is paramount to stress the importance of early detection of said diseases, as well as work to minimize the severity of their effects through proper funding of research and public awareness; and WHEREAS, Of these 7,000 rare diseases, more than 95% are without FDA approved treatment; and WHEREAS, Since many rare diseases and diseases of unmet need are genetic, tragically, approximately half the people affected by rare diseases in the United States are children; and WHEREAS, Research on rare diseases, which are serious and often life-threatening, is vitally important due to it frequently adds significantly to the general understanding of more common diseases and conditions; and WHEREAS, People suffering from rare diseases typically experience difficulty in obtaining a timely, accurate diagnosis, finding physicians or treatment centers and experience limited treatment options, options generally considered more expensive than those for common diseases; and WHEREAS, It typically takes between six to eight years on average to receive an accurate diagnosis; and WHEREAS, Biopharmaceutical research companies, academic researchers, patient groups, and others are applying the growing understanding of the causes of rare diseases to speed the development of new treatments for patients; the Orphan Drug Act of 1983 has been and continues to be an important force in driving treatment innovation for rare diseases; and WHEREAS, Advances in DNA sequencing have led to the identification of the genetic cause of several rare disease, which can potentially lead to better understanding of the disease and development of targeted therapies; and WHEREAS, In 2020, legislation creating a Rare Disease Advisory Work Group was signed into law; this Work Group will be composed of individuals with expertise in rare disease who will focus on best practices that will: improve awareness of rare diseases; and evaluate barriers to treatment including financial barriers on access to care; and WHEREAS, In 2020, legislation creating a Rare Disease Advisory Work Group was signed into law; this Work Group will be composed of individuals with expertise in rare disease who will focus on improving awareness of rare diseases and evaluating barriers to treatment, including financial barriers; and WHEREAS, Today, there is more hope than ever before with over 560 medicines in development for patients with rare diseases; medicines in development include 151 for rare cancers and 82 for rare blood cancers, accounting for 40 percent of all rare disease medicines in development;
148 for genetic disorders, including cystic fibrosis and spinal muscular atrophy; 38 for neurological disorders, including amyotrophic lateral sclerosis (ALS) and seizures; 31 for infectious diseases, including rare bacterial infections and hepatitis; 25 for… Show allHide
148 for genetic disorders, including cystic fibrosis and spinal muscular atrophy; 38 for neurological disorders, including amyotrophic lateral sclerosis (ALS) and seizures; 31 for infectious diseases, including rare bacterial infections and hepatitis; 25 for autoimmune diseases, including systemic sclerosis and juvenile arthritis; and WHEREAS, Currently, research has led to powerful new gene-editing techniques holding promise for cures for blood disorders (such as Sickle Cell Disease, Thalassemia, Hemophilia), Cancer, Blindness, Aids, Muscular Dystrophy, Cystic Fibrosis, and Huntington's disease; and WHEREAS, These treatment options and medicines in development attack the root of the cause for these patients that had few or no treatment options before; and WHEREAS, It is imperative that there be greater public awareness of rare diseases and diseases of unmet need, and more must be done to increase activity at the local, state and national levels to support those afflicted as well as their families and caregivers; now, therefore, be it RESOLVED, That this Legislative Body pause in its deliberations to memorialize Governor Kathy Hochul to proclaim February 28, 2023, as Rare Disease Day in the State of New York; and be it further RESOLVED, That copies of this Resolution, suitably engrossed, be transmitted to The Honorable Kathy Hochul, Governor of the State of New York; the New York State Rare Disease Alliance; and NORD.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.